Sanofi Consumer Healthcare India Limited has intimated the stock exchanges about an upcoming Board of Directors meeting scheduled for Wednesday, 28th October 2026.
The primary agenda of the board meeting is to consider and approve the company's Unaudited Financial Results for the quarter and nine months ended 30th September 2026. This disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Additionally, the company references its previous communication dated 28th September 2026 regarding the trading window closure. As per the Sanofi Consumer Healthcare India Limited Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, the trading window remains closed from Thursday, 1st October 2026 to Friday, 30th October 2026 (both days inclusive) due to the publication of the unaudited financial results.
The intimation was digitally signed by Nikunjkumar Jaysukhlal Savaliya, Company Secretary and Compliance Officer (Membership No.: F7048), on 22nd October 2026 at 17:07:05 IST.